TREE NEWS update: Bepirovirsen, the world’s first functional cure drug for hepatitis B, achieved up to 61% functional cure rate in Chinese patients, according to data from the global Phase III B-Well study presented by Professor Hou Jinlin at the Asian Hepatology Summit in Singapore on September 4. The drug was approved in Japan in August.
Bepirovirsen shows 61% functional cure rate in Chinese HBV patients
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
16m ago
China Bulk Commodity Market to Stay Stable in Q4 Peak Season
27m ago
Israeli Airstrikes Kill at Least 5 in Southern Lebanon
35m ago
Iraq to Receive Gasoline Shipments to Ease Shortage
45m ago
US Offers Nvidia Chips Access in Armenia-Azerbaijan Peace Deal
47m ago
DoubleLine credit chief sees value in big tech bonds after AI selloff
1h ago
Middle East shipping rates jump over 50% as Red Sea crisis persists